The Animal Placental Protein Market Size is valued at USD 527.09 Mn in 2022 and is predicted to reach USD 837.97 Mn by the year 2031 at a 5.5% CAGR during the forecast period for 2023-2031.
Animal placental proteins refer to proteins that are obtained from the placentas of various animal species. The placenta is an organ that undergoes development during pregnancy in the majority of animal species, including humans. Its initial function is to facilitate the exchange of nutrients, gases, and debris between the maternal and foetal circulatory systems.
Placental proteins are known to contain bioactive compounds such as growth factors, cytokines, and peptides. These molecules have demonstrated potential for a variety of uses, including wound healing, skin rejuvenation, and immunological regulation, which has fueled market interest. Growing healthcare and aesthetic sectors in developing economies provide new market prospects for goods utilizing animal placental proteins. Increased consumer spending on healthcare and personal care products may result from economic growth in certain destinations.
However, the animal placental protein market, like many others, may have encountered supply chain delays as a result of lockdowns, travel restrictions, and logistical issues. This could have affected placental tissue collection, processing, and transportation.
Competitive Landscape
Some major key players in the Animal Placental Protein Market:
- Sigma-Aldrich Corporation (Now part of Merck KGaA)
- Biotain Pharma Co., Ltd.
- New Zealand Health Food Company Limited
- XABC Biotech Co., Ltd.
- BIOFAC A/S
- Chaitanya Biologicals Pvt. Ltd.
- Serolab SA
- Auckland BioSciences Limited
- ANZCO Foods Limited
- Biocontinental Co., Ltd.
- Japan Bio Products (Japan)
- Bovogen Biologicals (Australia)
Market Segmentation:
The Animal Placental Protein Market is segmented on the basis of product type, application, animal source, end-user, and distribution channel. As per the product type, the market is segmented as Animal Placental Protein Extracts, Animal Placental Protein Powders, Animal Placental Protein Capsules/Tablets, and Animal Placental Protein Injections.
The application segment includes Pharmaceuticals (including human and veterinary medicine), Cosmetics and Personal Care Products, Nutraceuticals and Dietary Supplements, and Research and Biotechnology. By animal source, the market is segmented into Bovine (cow), Porcine (pig), Ovine (sheep), Equine (horse), and Others (e.g., deer, kangaroo). The end-user segment includes Pharmaceutical Companies, Cosmetics and Personal Care Companies, Nutraceutical and Dietary Supplement Manufacturers, Research Institutions and Laboratories. The market is divided by distribution channel into Direct Sales (B2B), Retail Sales (B2C), and Online Retail.
Based On Application, The Pharmaceuticals Segment Is Accounted As A Major Contributor In The Animal Placental Protein Market
The Pharmaceuticals category is expected to hold a major share of the global Animal Placental Protein Market in 2022. Bioactive chemicals in animal placental proteins may enhance tissue regeneration and wound healing. Certain growth factors and cytokines found in placental tissues may have the potential to expedite the healing of chronic wounds, diabetic ulcers, and tissue damage, according to research. Growth factors found in placental proteins may increase cell proliferation and tissue regeneration. These proteins could be exploited to create therapeutics for tissue injury or degeneration diseases.
The Pharmaceutical Companies Segment Witnessed Growth At A Rapid Rate
The Pharmaceutical Companies segment is projected to grow rapidly in the global Animal Placental Protein Market. As public awareness of natural and physiologically active medicines grows, pharmaceutical companies may anticipate an increase in demand for goods containing animal placental proteins. Collaborations with pharmaceutical corporations, research institutes, and academic institutions can help to accelerate the development of placental protein-based medicines. For successful product development, partnerships bring together varied knowledge and resources.
In The Region, The North American Animal Placental Protein Market Holds A Significant Revenue Share
The North American animal Placental Protein Market is expected to record the highest share in revenue in the near future. The rising usage of placental protein in cosmetics, dietary supplements, & other health and wellness products has increased demand for animal placental protein in North America. Anti-ageing and skin-rejuvenating creams continue to be popular in North America. The potential benefits of animal placental proteins in skincare products have piqued the cosmetics industry's interest. Moreover, Asia-Pacific's strong demand for animal placental protein is linked to the region's burgeoning population and rising disposable income.
Animal Placental Protein Market Report Scope:
|
Report Attribute |
Specifications |
|
Market size value in 2022 |
USD 527.09 Mn |
|
Revenue forecast in 2031 |
USD 837.97 Mn |
|
Growth rate CAGR |
CAGR of 5.5 % from 2023 to 2031 |
|
Quantitative units |
Representation of revenue in US$ Mn and CAGR from 2023 to 2031 |
|
Historic Year |
2019 to 2022 |
|
Forecast Year |
2023-2031 |
|
Report coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments covered |
By Product Type, By Application, By Animal Source, By End-user, By Distribution Channel |
|
Regional scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
|
Competitive Landscape |
Sigma-Aldrich Corporation (Now part of Merck KGaA), Biotain Pharma Co., Ltd., New Zealand Health Food Company Limited, XABC Biotech Co., Ltd., BIOFAC A/S, Chaitanya Biologicals Pvt. Ltd., Serolab SA, Auckland BioSciences Limited, ANZCO Foods Limited, Biocontinental Co., Ltd., Japan Bio Products (Japan), Bovogen Biologicals (Australia) |
|
Customization scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing and available payment methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Corporate
Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
info@insightaceanalytic.com
